يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Naab Al-Saady"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Kozieł, M, Al-Saady, N, Hjortshøj, S P, Goudev, A, Huber, K, Cohen, A, Jin, J, Melino, M, Winters, S M, Goette, A & Lip, G Y H 2020, ' Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial ', Clinical Research in Cardiology, vol. 109, no. 8, pp. 1018-1024 . https://doi.org/10.1007/s00392-019-01594-9
    CLINICAL RESEARCH IN CARDIOLOGY
    Clinical Research in Cardiology

    وصف الملف: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7

    المصدر: Lip, G Y H, Al-Saady, N, Ezekowitz, M D, Banach, M & Goette, A 2017, ' The relationship of renal function to outcome : A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study ', American Heart Journal, vol. 193, pp. 16-22 . https://doi.org/10.1016/j.ahj.2017.07.010

    وصف الملف: application/pdf

  8. 8

    المساهمون: ACS - Amsterdam Cardiovascular Sciences, Cardiology

    المصدر: Goette, A, Merino, J L, Ezekowitz, M D, Zamoryakhin, D, Melino, M, Jin, J, Mercuri, M F, Grosso, M A, Fernandez, V, Al-Saady, N, Pelekh, N, Merkely, B, Zenin, S, Kushnir, M, Spinar, J, Batushkin, V, de Groot, J R & Lip, G Y H 2016, ' Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF) : a randomised, open-label, phase 3b trial ', Lancet, vol. 388, no. 10055, pp. 1995-2003 . https://doi.org/10.1016/S0140-6736(16)31474-X
    Lancet, 388(10055), 1995-2003. Elsevier Limited
    ResearcherID

  9. 9
  10. 10